On 2025-12-23, Bright Minds Biosciences Inc. (DRUG) announced earnings per share of $-0.41 for the fiscal quarter ending 2025-09-30, beating the average analyst estimate of $-0.70.
The next expected annoucement date for quarterly earnings is 2026-02-12, with an average estimated earnings per share of $-0.98 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-12-23 | 2025-09-30 | $-0.70 | $-0.41 |
| 2025-08-14 | 2025-06-30 | $-0.59 | $-0.53 |
| 2025-05-15 | 2025-03-31 | $-0.39 | $-0.29 |
| 2025-02-13 | 2024-12-31 | $-0.23 | $0.01 |
| 2024-12-30 | 2024-09-30 | -- | $-0.12 |
| 2024-08-14 | 2024-06-30 | -- | $0.04 |
| 2024-05-15 | 2024-03-31 | -- | $-0.10 |
| 2024-02-12 | 2023-12-31 | -- | $-0.32 |
| 2023-12-29 | 2023-09-30 | -- | $-0.30 |
| 2023-08-14 | 2023-06-30 | -- | $-0.29 |
| 2023-05-15 | 2023-03-31 | -- | $-0.40 |
| 2023-02-07 | 2022-12-31 | -- | $-0.50 |
| 2022-12-29 | 2022-09-30 | -- | $-0.75 |
| 2022-08-12 | 2022-06-30 | -- | $-0.85 |
| 2022-05-16 | 2022-03-31 | -- | $-1.50 |
| 2022-02-14 | 2021-12-31 | -- | $-1.65 |